News & Trends - Pharmaceuticals
Pfizer files lawsuit to cease sale of biosimilar
Pharma News: Pfizer has filed Federal Court proceedings to halt the sale of a drug that is a biosimilar to the company’s rheumatoid arthritis medication.
The lawsuit against Samsung Bioepis, Merck, Sharp & Dohme (MSD), Organon, and Arrotex, seeks to to halt sales of the biosimilar Brenzys which was listed on the Pharmaceutical Benefits Scheme (PBS) in 2017.
In its lawsuit Pfizer claims the drug companies infringed one of its patents relating to Enbrel titled “Production of polypeptides” by agreeing to manufacture and sell Brenzys in Australia.
Pfizer is seeking compensation for financial losses allegedly suffered because of the sale of Brenzys in Australia and court orders barring the sale of the drug until its patent expires in August 2025.
Enbrel (etanercept) brought in around $1.7 billion in revenue for Pfizer from sales outside the USA and Canada in 2021, according to the company’s most recent financial results.
Pfizer strengthens position to ‘win the digital race in pharma’
The Health Industry Hub news and professional development content are copyright protected and access is provided under individual user licenses. For more information, visit https://www.healthindustryhub.com.au/membership/ and T&Cs.
News & Trends - MedTech & Diagnostics
$54 million cancer centre opens in one of Australia’s fastest growing communities
MedTech & Diagnostics News: Cancer care provider, GenesisCare, is now treating patients at a new $54 million integrated cancer centre […]
MoreMarketing & Strategy
Bayer, MSD and Takeda among winners at Asia Pacific awards
Bayer, MSD, Takeda, Alcon, and Cipla emerge as winners among this week’s announcements of Asia Pacific awards which celebrate organisations […]
MoreNews & Trends - MedTech & Diagnostics
Queensland elevates diagnostic precision with cutting-edge imaging technology
MedTech & Diagnostics News: Mackay Base Hospital and Qscan Mackay have unveiled state-of-the-art medical imaging machines to elevate patient care […]
MoreNews & Trends - Pharmaceuticals
Landmark collaboration sparks inauguration of precision care clinic
Pharma News: In a landmark collaboration, Australians with cancer will receive more personalised care through the newly established Precision Care […]
More